Cell No. : Cell Name
RCB5700 : ATG2A KO HeLa
update : 2024/05/07
|
Comment | Currently not ready. |
Comment from the depositor | HeLa in which ATG2A gene was deleted using CRISPR/Cas9-mediated genome editing. |
Terms and conditions | |
Remarks | CRISPR/Cas9 genome edited bioresources Announcement of bioresources developed by the CRISPR/Cas9 technology. |
Order Form |
|
Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp).
|
|
Basic information
|
Expected time |
Upon a request we will start preparation. Contact us: cellkitaku.brc@riken.jp
|
Reference information |
Reference |
1
|
User's Publication |
0
|